These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8891258)

  • 1. Intracerebroventricular infusion of the CCKB receptor agonist pentagastrin potentiates acoustic startle.
    Frankland PW; Josselyn SA; Bradwejn J; Vaccarino FJ; Yeomans JS
    Brain Res; 1996 Sep; 733(1):129-32. PubMed ID: 8891258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of amygdala cholecystokininB receptors potentiates the acoustic startle response in the rat.
    Frankland PW; Josselyn SA; Bradwejn J; Vaccarino FJ; Yeomans JS
    J Neurosci; 1997 Mar; 17(5):1838-47. PubMed ID: 9030642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CCKB antagonist, L-365,260, attenuates fear-potentiated startle.
    Josselyn SA; Frankland PW; Petrisano S; Bush DE; Yeomans JS; Vaccarino FJ
    Peptides; 1995; 16(7):1313-5. PubMed ID: 8545257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased CCK(B) receptor binding in rat amygdala in animals demonstrating greater anxiety-like behavior.
    Wunderlich GR; Raymond R; DeSousa NJ; Nobrega JN; Vaccarino FJ
    Psychopharmacology (Berl); 2002 Nov; 164(2):193-9. PubMed ID: 12404082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pentagastrin and the cold pressor test on the acoustic startle response and pupillary function in man.
    Tavernor SJ; Abduljawad KA; Langley RW; Bradshaw CM; Szabadi E
    J Psychopharmacol; 2000; 14(4):387-94. PubMed ID: 11198057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Light-enhanced and fear-potentiated startle: temporal characteristics and effects of alpha-helical corticotropin-releasing hormone.
    de Jongh R; Groenink L; van der Gugten J; Olivier B
    Biol Psychiatry; 2003 Nov; 54(10):1041-8. PubMed ID: 14625146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin-releasing factor: long-lasting facilitation of the acoustic startle reflex.
    Liang KC; Melia KR; Miserendino MJ; Falls WA; Campeau S; Davis M
    J Neurosci; 1992 Jun; 12(6):2303-12. PubMed ID: 1351540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological analysis of fear-potentiated startle.
    Davis M
    Braz J Med Biol Res; 1993 Mar; 26(3):235-60. PubMed ID: 8257926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated stress, like vasopressin, sensitizes the excitatory effects of corticotropin releasing factor on the acoustic startle reflex.
    Pelton GH; Lee Y; Davis M
    Brain Res; 1997 Dec; 778(2):381-7. PubMed ID: 9459555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lesions of the central nucleus of the amygdala, but not the paraventricular nucleus of the hypothalamus, block the excitatory effects of corticotropin-releasing factor on the acoustic startle reflex.
    Liang KC; Melia KR; Campeau S; Falls WA; Miserendino MJ; Davis M
    J Neurosci; 1992 Jun; 12(6):2313-20. PubMed ID: 1607942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CRH1 antagonist GSK561679 increases human fear but not anxiety as assessed by startle.
    Grillon C; Hale E; Lieberman L; Davis A; Pine DS; Ernst M
    Neuropsychopharmacology; 2015 Mar; 40(5):1064-71. PubMed ID: 25430779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of amygdaloid dopamine D2 receptors impairs emotional learning measured with fear-potentiated startle.
    Greba Q; Gifkins A; Kokkinidis L
    Brain Res; 2001 Apr; 899(1-2):218-26. PubMed ID: 11311883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GABA and opioid mechanisms of the central amygdala underlie the withdrawal-potentiated startle from acute morphine.
    Cabral A; Ruggiero RN; Nobre MJ; Brandão ML; Castilho VM
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):334-44. PubMed ID: 19150477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
    Singh L; Field MJ; Hughes J; Menzies R; Oles RJ; Vass CA; Woodruff GN
    Br J Pharmacol; 1991 Sep; 104(1):239-45. PubMed ID: 1686205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development changes in pharmacological responsivity of the acoustic startle reflex: effects of picrotoxin.
    Gallager DW; Kehne JH; Wakeman EA; Davis M
    Psychopharmacology (Berl); 1983; 79(2-3):87-93. PubMed ID: 6405442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal vs. supraspinal sites of action of the alpha 2-adrenergic agonists clonidine and ST-91 on the acoustic startle reflex.
    Davis M; Commissaris RL; Yang S; Wagner KR; Kehne JH; Cassella JV; Boulis NM
    Pharmacol Biochem Behav; 1989 May; 33(1):233-40. PubMed ID: 2571168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of systemic and intra-amygdaloid diazepam on long-term habituation of acoustic startle in rats.
    Young BJ; Helmstetter FJ; Rabchenuk SA; Leaton RN
    Pharmacol Biochem Behav; 1991 Aug; 39(4):903-9. PubMed ID: 1763110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of pertussis toxin sensitive G-proteins in conditioned fear-potentiated startle: possible involvement of the amygdala.
    Melia KR; Falls WA; Davis M
    Brain Res; 1992 Jul; 584(1-2):141-8. PubMed ID: 1515934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microinjections of the metabotropic glutamate receptor agonist, trans-(+/-)-1-amino-cyclopentane-1,3-dicarboxylate (trans-ACPD) into the amygdala increase the acoustic startle response of rats.
    Koch M
    Brain Res; 1993 Nov; 629(1):176-9. PubMed ID: 8287275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amygdaloid GABA, not glutamate neurotransmission or mRNA transcription controls footshock-associated fear arousal in the acoustic startle paradigm.
    Van Nobelen M; Kokkinidis L
    Neuroscience; 2006; 137(2):707-16. PubMed ID: 16289581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.